1. Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesity
- Author
-
Melvin R. Hayden, Javad Habibi, Annayya R. Aroor, Lixin Ma, Nathan Rehmer, James R. Sowers, and Brian Bostick
- Subjects
Male ,medicine.medical_specialty ,Heart disease ,Cardiac fibrosis ,Endocrinology, Diabetes and Metabolism ,Biology ,Article ,Dipeptidyl peptidase ,Mice ,Endocrinology ,Microscopy, Electron, Transmission ,Diastole ,Fibrosis ,Internal medicine ,medicine ,Animals ,Obesity ,Dipeptidyl peptidase-4 ,Dipeptidyl-Peptidase IV Inhibitors ,Triazoles ,medicine.disease ,Diet ,Mice, Inbred C57BL ,Disease Models, Animal ,Heart failure ,Myocardial fibrosis ,Metabolic syndrome ,Cardiomyopathies - Abstract
Consumption of a high-fat/high-fructose Western diet (WD) is linked to rising obesity and heart disease, particularly diastolic dysfunction which characterizes early obesity/metabolic cardiomyopathy. Mounting evidence supports a role for inflammation, oxidative stress and fibrosis in the pathophysiology of metabolic cardiomyopathy. Dipeptidyl peptidase-4 (DPP-4) is a circulating exopeptidase recently reported to be elevated in the plasma of patients with insulin resistance (IR), obesity and heart failure. We hypothesized that a model of WD induced obesity/metabolic cardiomyopathy would exhibit increased DPP-4 activity and cardiac fibrosis with DPP-4 inhibition preventing cardiac fibrosis and the associated diastolic dysfunction.Four-week-old C57BL6/J mice were fed a high-fat/high-fructose WD with the DPP-4 inhibitor MK0626 for 16 weeks. Cardiac function was examined by high-resolution cine-cardiac magnetic resonance imaging (MRI). Phenotypic analysis included measurements of body and heart weight, systemic IR and DPP-4 activity. Immunohistochemistry and transmission electron microscopy (TEM) were utilized to identify underlying pathologic mechanisms.We found that chronic WD consumption caused obesity, IR, elevated plasma DPP-4 activity, heart enlargement and diastolic dysfunction. DPP-4 inhibition with MK0626 in WD fed mice resulted in75% reduction in plasma DPP-4 activity, improved IR and normalized diastolic relaxation. WD consumption induced myocardial oxidant stress and fibrosis with amelioration by MK0626. TEM of hearts from WD fed mice revealed abnormal mitochondrial and perivascular ultrastructure partially corrected by MK0626.This study provides evidence of a role for increased DPP-4 activity in metabolic cardiomyopathy and a potential role for DPP-4 inhibition in prevention and/or correction of oxidant stress/fibrosis and associated diastolic dysfunction.
- Published
- 2014
- Full Text
- View/download PDF